查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
蛋白質體學市場－全球及區域分析：按產品、技術、應用、最終用戶和地區分類－分析與預測（2025-2035）
市場調查報告書
商品編碼
1856052

蛋白質體學市場－全球及區域分析：按產品、技術、應用、最終用戶和地區分類－分析與預測（2025-2035）

Proteomics Market - A Global and Regional Analysis: Focus on Offering, Technology, Application, End User, and Regional Analysis - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 197 Pages | 商品交期: 1-5個工作天內

價格

全球蛋白質體學市場預計到 2025 年將達到約 296 億美元，預計到 2035 年將成長至 962.8 億美元，複合年成長率約為 12.52%。

全球蛋白質體學市場正經歷加速成長，這主要得益於慢性病和神經退化性疾病盛行率的上升、技術的不斷進步以及對個人化醫療日益成長的需求。蛋白質體學已成為一個變革性領域，能夠對蛋白質的結構、功能和相互作用進行深入分析，這對於闡明疾病機制和開發標靶治療至關重要。人工智慧、機器學習和多組體學平台的整合正在革新蛋白質體學的工作流程，從生物標記的發現到臨床應用，都能實現更快、更準確、更經濟高效的分析。人工智慧系統正在簡化數據解讀，揭示複雜的蛋白質相互作用網路，並透過預測建模促進疾病的早期檢測。

關鍵市場統計數據
預測期 2025-2035
2025 年估值 296億美元
2035 年預測 962.8億美元
複合年成長率 12.52%

此外，自主發現平台和生成式人工智慧工具正透過賦能研究人員以最小的人工干預迭代執行設計、測試和最佳化週期，加速藥物發現和診斷進程。製藥公司、生物技術公司和受託研究機構正日益與人工智慧主導的新興企業和技術提供商合作，以增強擴充性、改進數據整合並實現精準主導的洞察。策略夥伴關係、資金籌措計劃和併購正在加強先進蛋白質體學平台的商業化，而雲端基礎和本地部署解決方案則正在擴大其在研究和臨床環境中的可及性。這些因素共同重塑了全球蛋白質體學市場，提高了研究效率，並為其持續的長期成長奠定了基礎。

全球蛋白質體學市場生命週期階段

全球蛋白質體學市場目前正處於生命週期的成長和加速階段，從早期應用階段向更廣泛的市場成熟階段過渡。過去十年，該領域已從學術探索性研究發展成為精準醫療、臨床診斷和藥物研發中具有戰略意義的重要組成部分。這一轉變得益於質譜、液相層析法和親和層析蛋白質體學平台技術的快速發展，以及人工智慧、機器學習和多組體學分析的融合應用。

全球蛋白質體學市場的擴張得益於技術創新和臨床效用的強強聯合。數據非依賴性採集（DIA）方法、單細胞蛋白質組學、空間蛋白質組學以及生物資訊學流程的持續改進，使得高通量、高靈敏度的蛋白質譜分析成為可能。同時，商業性參與企業正透過自動化、雲端分析和服務型交付模式，不斷提昇平台的可近性。這些趨勢預示著蛋白質體學正從科研應用領域邁向臨床和轉化應用領域邁進。

儘管市場創新強度很高，但不同地區和終端用戶群的滲透率卻存在差異。北美和歐洲的研發市場在製藥、生物技術和學術研究生態系統中已接近主流化應用。相較之下，新興地區的應用仍處於早期發展階段，受到高昂的資本成本、基礎設施不足和技能人才匱乏等因素的限制。這種分化使得全球市場處於中後期成長階段，透過價格合理的設備、​​服務合作和分散式蛋白質體學網路，市場擁有龐大的擴張機會。

全球蛋白質體學市場正處於蓬勃發展階段，其特點是技術創新、資本流入和終端用戶應用日益普及。未來幾年，隨著臨床應用的進一步整合、工作流程的標準化以及技術提供者之間的整合，該產業預計將逐步成熟。

市場區隔

細分1：按產品

  • 樣品製備
  • 蛋白質體學技術
    • 試劑和耗材
    • 裝置
    • 軟體
  • 蛋白質體學服務

蛋白質體學技術領域預計將佔據全球蛋白質體學市場最大的佔有率。這主要歸功於質譜儀、層析法系統和專用軟體等先進分析平台的廣泛應用，這些平台為進行高通量、高解析度蛋白質組學分析奠定了基礎。儀器技術的持續創新、對平台特異性試劑日益成長的需求以及人工智慧和雲端基礎工具的日益融合，進一步鞏固了該領域的領先地位。此外，蛋白質體學技術相關的高額資本支出也顯著提升了整體市場價值。

細分2：依技術

  • 基於質譜的蛋白質體學
  • 基於層析法的蛋白質體學
  • 蛋白質微陣列
  • 單細胞蛋白質體學
  • 基於NGS的蛋白質體學
  • 其他

從技術角度來看，基於質譜的蛋白質體學預計將在2024年主導全球蛋白質體學市場，這主要歸功於其在識別和定量各種生物樣本中的蛋白質方面無與倫比的靈敏度、準確性和多功能性。質譜技術已成為蛋白質體學研究的黃金標準，因為它能夠支援發現和靶向工作流程，檢測轉譯後修飾，並處理複雜的樣本基質。其在臨床和轉化研究中的應用進一步推動了其在製藥、學術和診斷領域的普及。

細分3：按應用

  • 生物標記的發現與檢驗
  • 蛋白質體分析與作圖
  • 藥物發現與開發
    • 藥物發現
    • 臨床前試驗
    • 臨床試驗
  • 伴隨診斷
  • 蛋白質-蛋白質相互作用

預計到2024年，生物標記發現和檢驗領域將佔據全球蛋白質體學市場最大的佔有率。這一主導地位源於其在多個治療領域的廣泛應用、在精準醫療中的關鍵作用，以及由於其在早期研究、診斷和藥物開發中的作用而獲得的巨額資金。蛋白質體學的廣泛應用及其對各種蛋白質體學技術的依賴，使其成為最受追捧的應用領域。

細分 4：按最終用戶

  • 學術和研究機構
  • 製藥和生物技術公司
  • 臨床診斷實驗室和醫院
  • 受託研究機構

根據終端用戶細分，預計到2024年，學術和研究機構將佔據全球蛋白質體學市場最大的佔有率。這主要歸功於大學、政府資助的實驗室和公共研究中心所進行的大量基礎研究和轉化研究。這些研究機構處於新型蛋白質組學方法、生物標記發現和系統生物學領域的前沿，並通常獲得大量的公共和私人資金支持。此外，先進的基礎設施、與產業相關人員的合作以及對創新的高度重視，使學術和研究機構成為全球蛋白質體學應用的關鍵驅動力。

細分5：按地區

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

預計北美將在2024年佔據全球蛋白質體學市場最大佔有率，達到44.69%。這一主導地位歸功於該地區完善的研究基礎設施、主要市場參與企業的強大實力、對生命科學研發的高額投入，以及先進蛋白質體學技術在學術界和臨床領域的廣泛應用。同時，亞太地區預計將成為成長最快的地區，在預測期（2025-2035年）內將實現13.86%的複合年成長率。這主要得益於政府對生物醫學研究投入的不斷增加、醫療基礎設施的快速擴張、對精準醫療日益重視，以及全球企業與區域研究機構之間合作的日益密切。

需求——促進因素與限制因素

全球蛋白質體學市場需求促進因素：

  • 慢性病盛行率不斷上升
  • 持續的技術進步
  • 對個人化醫療的需求日益成長

全球蛋白質體學市場限制：

  • 高昂的購置成本阻礙了蛋白質體學技術的應用。
  • 熟練專業人員短缺

本報告旨在幫助企業識別全球蛋白質體學市場中的高價值機會。它指南研發投資策略、技術應用和產品線最佳化，幫助舉措優先推廣生物標記發現、疾病診斷和治療藥物開發。透過重點介紹新興技術、策略合作夥伴關係和平台擴充性，本報告助力企業獲得競爭優勢，並充分利用蛋白質體學在研究、臨床和製藥領域的快速發展。

本報告深入分析了區域市場採納趨勢、新興市場和夥伴關係機遇，旨在為企業製定策略性市場進入和商業化規劃提供支援。企業可以藉此識別產品、技術、應用和終端用戶等各個細分市場的成長潛力。了解區域研發投入、法規結構和技術採納率，有助於企業最佳化行銷、授權和合作策略，從而在全球競爭激烈的市場環境中最大限度地提升品牌知名度和投資回報率。

本報告提供全面的公司概況、競爭基準化分析、策略聯盟亮點、資金籌措活動、併購以及技術應用趨勢。相關人員可以清楚了解競爭對手的關注領域、研發重點和市場定位。這些資訊有助於企業識別差距、預測市場變化、實現差異化、最佳化市場進入策略，並制定策略以保持在蛋白質體學生態系統中的領先地位。

主要市場參與企業和競爭格局

全球蛋白質體學市場競爭激烈，老字型大小企業企業和新興企業企業均積極參與其中，市場格局不斷演變。主要參與企業包括生命科學儀器、耗材和生物資訊解決方案的領先供應商，以及提供質譜、蛋白質微陣列、層析法系統和數據分析平台等尖端技術的服務供應商。主要企業包括：

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Carterra, Inc.
  • Danaher Corporation
  • DiaSorin SPA
  • Erisyon Inc.
  • Illumina, Inc.
  • RareCyte Inc.
  • Quanterix Corporation
  • Quantum-Si Incorporated
  • Shimadzu Corporation
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation

競爭基準化分析著重於併購、資金籌措活動、授權合約和醫藥合作，體現了對創新和快速上市的日益重視。評估標準包括公司的市場佔有率、技術能力、策略舉措和產品系列。詳細的公司概況涵蓋目標終端使用者、技術重點領域和專家分析師的觀點，為相關人員提供有關投資機會、市場定位和策略成長路徑的可操作性見解。這些資訊有助於公司有效地調整其研發和商業化策略，以適應全球蛋白質體學市場的新興市場動態。

目錄

執行摘要

第1章 市場：產業展望

  • 市場概覽與生態系統
  • 與其他體學相比，蛋白質體學的比較優勢和劣勢
  • 供應鏈分析
  • 市場動態
  • 趨勢
    • 加速端到端蛋白質體學工作流程的自動化
    • 拓展蛋白質體學研究以識別疾病生物標記
    • 市場參與企業之間的眾多合作
  • 市場動態
  • 監管狀態/合規性
    • 美國
    • 歐洲
    • 其他地區
  • 專利分析
  • 產品基準測試

第2章 供品

  • 招股摘要
  • 全球蛋白質體學市場按產品/服務分類
    • 樣品製備
    • 蛋白質體學技術
    • 蛋白質體學服務

第3章 應用

  • 使用摘要
  • 全球蛋白質體學市場（按應用領域分類）
    • 生物標記的發現與檢驗
    • 蛋白質體分析與作圖
    • 藥物發現與開發
    • 伴隨診斷
    • 蛋白質-蛋白質相互作用

第4章 技術

  • 技術摘要
  • 全球蛋白質體學市場（按技術分類）
    • 基於質譜的蛋白質體學
    • 基於層析法的蛋白質體學
    • 蛋白質微陣列
    • 單細胞蛋白質體學
    • 基於NGS的蛋白質體學
    • 其他

第5章 最終用戶

  • 最終用戶摘要
  • 全球蛋白質體學市場（按最終用戶分類）
    • 學術研究機構
    • 製藥和生物技術公司
    • 醫院和臨床診斷實驗室
    • CRO

第6章 區域

  • 區域摘要
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

7. 市場－競爭基準化分析與公司概況

  • 公司簡介
    • Agilent Technologies, Inc.
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Bruker Corporation
    • Carterra, Inc.
    • Danaher Corporation
    • DiaSorin SPA
    • Erisyon Inc.
    • Illumina, Inc.
    • RareCyte Inc.
    • Quanterix Corporation
    • Quantum-Si Incorporated
    • Shimadzu Corporation
    • Standard BioTools Inc.
    • Thermo Fisher Scientific Inc.
    • Waters Corporation

第8章調查方法

Product Code: BHP1781SB

This report can be delivered within 1 working day.

Global Proteomics Market: Industry Overview

The global proteomics market was valued at approximately $29.60 billion in 2025 and is projected to grow $96.28 billion by 2035, at a CAGR of around 12.52%. The global proteomics market is witnessing accelerated growth driven by the rising prevalence of chronic and neurodegenerative diseases, continuous technological advancements, and the increasing demand for personalized medicine. Proteomics has emerged as a transformative field, enabling in-depth analysis of protein structures, functions, and interactions, which are critical for understanding disease mechanisms and developing targeted therapies. The integration of artificial intelligence, machine learning, and multi-omics platforms is revolutionizing the proteomics workflow, from biomarker discovery to clinical translation, by enabling faster, more accurate, and cost-effective analyses. AI-enabled systems are streamlining data interpretation, uncovering complex protein interaction networks, and facilitating early disease detection through predictive modeling.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$29.60 Billion
2035 Forecast$96.28 Billion
CAGR12.52%

Moreover, autonomous discovery platforms and generative AI tools are empowering researchers to perform iterative design, test, and optimize cycles with minimal human intervention, accelerating drug discovery and diagnostics. Pharmaceutical, biotechnology, and contract research organizations are increasingly collaborating with AI-driven startups and technology providers to enhance scalability, improve data integration, and enable precision-driven insights. Strategic partnerships, funding initiatives, and mergers are strengthening the commercialization of advanced proteomic platforms, while cloud-based and on-premise solutions are expanding accessibility across research and clinical settings. Collectively, these factors are reshaping the global proteomics landscape, improving research productivity, and positioning the market for sustained long-term growth.

Global Proteomics Market Lifecycle Stage

The global proteomics market currently stands at the growth and acceleration stage of its lifecycle, transitioning from early adoption toward broader market maturity. Over the past decade, the field has evolved from academic and exploratory research into a strategically critical component of precision medicine, clinical diagnostics, and drug discovery. This shift has been fueled by rapid advancements in mass spectrometry, liquid chromatography, and affinity-based proteomic platforms, alongside the integration of artificial intelligence, machine learning, and multi-omics analytics.

The expansion of the global proteomics market is underpinned by a robust convergence of technological innovation and clinical utility. Continuous improvements in data-independent acquisition (DIA) methods, single-cell and spatial proteomics, and bioinformatics pipelines are enabling high-throughput, high-sensitivity protein profiling. At the same time, commercial players are scaling platform accessibility through automation, cloud-enabled analytics, and service-based delivery models. These trends indicate strong forward momentum as proteomics moves beyond research applications into clinical and translational domains.

While the market exhibits high innovation intensity, its penetration remains uneven across regions and end-user segments. Developed markets in North America and Europe demonstrate near-mainstream adoption within pharma, biotech, and academic research ecosystems. Conversely, adoption in emerging regions is still in its early growth phase, constrained by high capital costs, infrastructure gaps, and limited skilled personnel. This bifurcation positions the market globally within a mid-to-late growth phase, with significant opportunities for expansion through affordable instrumentation, service partnerships, and decentralized proteomic networks.

In summary, the global proteomics market is in a dynamic growth stage, characterized by technological disruption, capital inflows, and expanding end-user adoption. Over the next few years, the industry is expected to move toward early maturity, with broader clinical integration, standardization of workflows, and consolidation among technology providers.

Market Segmentation:

Segmentation 1: By Offering

  • Sample Preparation
  • Proteomics Technologies
    • Reagents and Consumables
    • Instruments
    • Software
  • Proteomics Services

Proteomics technologies segment is expected to account for the largest share of the global proteomics market. This can be attributed to the widespread adoption of advanced analytical platforms, including mass spectrometry, chromatography systems, and specialized software, which are fundamental to conducting high-throughput and high-resolution proteomic analyses. The continuous innovation in instrumentation, growing demand for platform-specific reagents, and increasing integration of AI and cloud-based tools have further strengthened the dominance of this segment. Additionally, the high capital investment associated with proteomic technologies contributes significantly to overall market value.

Segmentation 2: By Technology

  • Mass Spectrometry-Based Proteomics
  • Chromatography-Based Proteomics
  • Protein Microarrays
  • Single-Cell Proteomics
  • NGS-Based Proteomics
  • Others

Based on technology, mass spectrometry-based proteomics is expected to dominate the global proteomics market in 2024. This is primarily due to its unmatched sensitivity, accuracy, and versatility in identifying and quantifying proteins across diverse biological samples. Mass spectrometry has become the gold standard in proteomic research owing to its ability to support both discovery and targeted workflows, detect post-translational modifications, and handle complex sample matrices. Its integration into clinical and translational research has further expanded its adoption across pharmaceutical, academic, and diagnostic settings.

Segmentation 3: By Application

  • Biomarker Discovery and Validation
  • Proteome Profiling and Mapping
  • Drug Discovery and Development
    • Discovery
    • Preclinical
    • Clinical
  • Companion Diagnostics
  • Protein-Protein Interactions

In 2024, biomarker discovery and validation segment is projected to hold the largest share of the global proteomics market. This dominance is driven by its wide usage across multiple therapeutic areas, integral to precision medicine, and heavily funded for its role in early-stage research, diagnostics, and drug development. Its broad applicability and reliance on diverse proteomics technologies make it the most in-demand application

Segmentation 4: By End User

  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Clinical Diagnostic Laboratory & Hospitals
  • Contract Research Organizations

Based on end-user segmentation, academic and research institutions are expected to account for the largest share of the global proteomics market in 2024. This is primarily driven by the high volume of basic and translational research activities conducted in universities, government-funded laboratories, and public research centers. These institutions are at the forefront of exploring novel proteomic methodologies, biomarker discovery, and systems biology, often supported by significant public and private funding. Additionally, the availability of advanced infrastructure, collaborations with industry players, and a strong focus on innovation have positioned academic and research institutions as key drivers of proteomics adoption globally.

Segmentation 5: By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Based on region, North America is expected to hold the largest share of the global proteomics market in 2024, accounting for 44.69%. This dominance is attributed to the region's well-established research infrastructure, strong presence of key market players, high investment in life sciences R&D, and widespread adoption of advanced proteomic technologies in both academic and clinical settings. Meanwhile, Asia-Pacific is projected to be the fastest-growing region during the forecast period (2025-2035), with a CAGR of 13.86%, driven by increasing government funding for biomedical research, rapid expansion of healthcare infrastructure, growing focus on precision medicine, and a rising number of collaborations between global companies and regional research institutions.

Demand - Drivers and Limitations

Demand Drivers for the Global Proteomics Market:

  • Rising Prevalence of Chronic Diseases
  • Continuous Technological Advancements
  • Increasing Demand for Personalized Medicine

Limitations for the Global Proteomics Market:

  • High Costs of Acquisition Hindering the Adoption of Proteomics Technologies
  • Shortage of Skilled Professionals

How can this report add value to an organization?

Product/Innovation: This report enables organizations to identify high-value opportunities in the global proteomics market. It guides R&D investment strategies, technology adoption, and pipeline optimization, helping companies prioritize initiatives that accelerate biomarker discovery, disease diagnostics, and therapeutic development. By highlighting emerging technologies, strategic collaborations, and platform scalability, this report helps organizations strengthen their competitive positioning and capitalize on the rapid expansion of proteomics across research, clinical, and pharmaceutical applications.

Growth/Marketing: The report delivers in-depth insights into regional adoption trends, emerging markets, and partnership opportunities, supporting strategic market entry and commercialization planning. It enables companies to identify growth potential across offering, technology, application, and end-user segments. By understanding regional R&D investments, regulatory frameworks, and technology adoption rates, organizations can refine marketing, licensing, and collaboration strategies, maximize visibility, and increase return on investment in a competitive global landscape.

Competitive: This report provides comprehensive company profiling, competitive benchmarking, highlighting strategic collaborations, funding activities, mergers, acquisitions, and technology adoption trends. Stakeholders gain a clear understanding of competitor focus areas, R&D priorities, and market positioning. This intelligence allows organizations to identify gaps, anticipate market shifts, and formulate strategies to differentiate themselves, optimize market entry, and maintain leadership in the proteomics ecosystem.

Key Market Players and Competitive Landscape

The global proteomics market is characterized by a highly competitive and evolving landscape, with participation from both well-established and emerging start-up companies. The key players include leading providers of life science instruments, consumables, and bioinformatics solutions offering advanced technologies such as mass spectrometry, protein microarrays, chromatography systems, and data analysis platforms as well as service providers. Key players include:

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Carterra, Inc.
  • Danaher Corporation
  • DiaSorin S.P.A.
  • Erisyon Inc.
  • Illumina, Inc.
  • RareCyte Inc.
  • Quanterix Corporation
  • Quantum-Si Incorporated
  • Shimadzu Corporation
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation

Competitive benchmarking highlights mergers and acquisitions, funding activities, licensing deals, and collaborations with pharmaceutical organizations, reflecting the growing emphasis on innovation and speed-to-market. Companies are evaluated based on market presence, technological capabilities, strategic initiatives, and product portfolios. Detailed company profiles cover target end users, technological focus areas, and expert analyst perspectives, providing stakeholders with actionable insights into investment opportunities, market positioning, and strategic growth pathways. This intelligence enables organizations to effectively align their R&D and commercialization strategies with emerging market dynamics of the global proteomics market.

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Market Overview and Ecosystem
  • 1.2 Comparative Advantages and Disadvantages of Proteomics Over Other Omics
  • 1.3 Supply Chain Analysis
  • 1.4 Market Dynamics
    • 1.4.1 Trends, Drivers, Challenges, and Opportunities: Current and Future Impact Assessment, 2024-2035
  • 1.5 Trends
    • 1.5.1 Increasing Automation for End-to-End Proteomics Workflow
    • 1.5.2 Growing Proteomics Research to Identify Disease Biomarkers
    • 1.5.3 Significant Number of Collaborations among Market Players
  • 1.6 Market Dynamics
    • 1.6.1 Market Drivers
      • 1.6.1.1 Rising Prevalence of Chronic Diseases
      • 1.6.1.2 Continuous Technological Advancements
      • 1.6.1.3 Increasing Demand for Personalized Medicine
    • 1.6.2 Market Challenges
      • 1.6.2.1 High Costs of Acquisition Hindering the Adoption of Proteomics Technologies
      • 1.6.2.2 Shortage of Skilled Professionals
    • 1.6.3 Business Strategies
      • 1.6.3.1 Key Product Launch/Expansion
    • 1.6.4 Corporate Strategies
      • 1.6.4.1 Key Partnerships
      • 1.6.4.2 Key Funding and Grants
      • 1.6.4.3 Key Merger and Acquisitions
    • 1.6.5 Market Opportunities
      • 1.6.5.1 Expanding Proteomics Market in Emerging Regions through Affordable Technologies
  • 1.7 Regulatory Landscape/Compliance
    • 1.7.1 U.S.
      • 1.7.1.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
      • 1.7.1.2 Regulatory Requirements for Research Use Only (RUO) Products
      • 1.7.1.3 Requirements under the Clinical Laboratory Improvement Amendments (CLIA) for Clinical Proteomics Labs
    • 1.7.2 Europe
      • 1.7.2.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
        • 1.7.2.1.1 EU Medical Device Regulation
        • 1.7.2.1.2 EU In Vitro Diagnostic Regulation
        • 1.7.2.1.3 Regulatory Requirements for Clinical Proteomics Labs in the EU
    • 1.7.3 Rest-of-the-World
      • 1.7.3.1 China
        • 1.7.3.1.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
      • 1.7.3.2 Japan
        • 1.7.3.2.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
      • 1.7.3.3 Brazil
        • 1.7.3.3.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
        • 1.7.3.3.2 Regulatory Requirements for Clinical Proteomics Labs in Brazil
  • 1.8 Patent Analysis
    • 1.8.1 Patent Analysis (by Year)
    • 1.8.2 Patent Analysis (by Country)
  • 1.9 Product Benchmarking

2 Offering

  • 2.1 Offering Summary
  • 2.2 Global Proteomics Market (by Offering)
    • 2.2.1 Sample Preparation
    • 2.2.2 Proteomics Technologies
      • 2.2.2.1 Reagents and Consumables
        • 2.2.2.1.1 MS-Based Reagents
        • 2.2.2.1.2 Chromatography-Based Reagents
        • 2.2.2.1.3 Protein Microarray Reagents
        • 2.2.2.1.4 Single-Cell Analysis Reagents
        • 2.2.2.1.5 NGS-Based Reagents
        • 2.2.2.1.6 Other Reagents
      • 2.2.2.2 Instruments
        • 2.2.2.2.1 Mass Spectrometers
        • 2.2.2.2.2 Chromatography Systems
        • 2.2.2.2.3 Protein Microarrays
        • 2.2.2.2.4 Single-Cell Analysis Instruments
        • 2.2.2.2.5 NGS Instruments
        • 2.2.2.2.6 Other Instruments
      • 2.2.2.3 Software
        • 2.2.2.3.1 AI-Based Proteomics Analysis Tools
        • 2.2.2.3.2 Spatial Proteomics Data Analytic Software
        • 2.2.2.3.3 Cloud-Based Platforms
    • 2.2.3 Proteomics Services

3 Application

  • 3.1 Application Summary
  • 3.2 Global Proteomics Market (by Application)
    • 3.2.1 Biomarker Discovery and Validation
    • 3.2.2 Proteome Profiling and Mapping
    • 3.2.3 Drug Discovery and Development
      • 3.2.3.1 Discovery
        • 3.2.3.1.1 Target Identification and Validation
        • 3.2.3.1.2 Others
      • 3.2.3.2 Preclinical
      • 3.2.3.3 Clinical
    • 3.2.4 Companion Diagnostics
    • 3.2.5 Protein-Protein Interactions

4 Technology

  • 4.1 Technology Summary
  • 4.2 Global Proteomics Market (by Technology)
    • 4.2.1 Mass Spectrometry-Based Proteomics
    • 4.2.2 Chromatography-Based Proteomics
    • 4.2.3 Protein Microarray
    • 4.2.4 Single-Cell Proteomics
    • 4.2.5 NGS-Based Proteomics
    • 4.2.6 Other Technologies

5 End User

  • 5.1 End User Summary
  • 5.2 Global Proteomics Market (by End User)
    • 5.2.1 Academic and Research Institutions
    • 5.2.2 Pharmaceutical and Biotechnology Companies
    • 5.2.3 Hospitals and Clinical Diagnostics Laboratories
    • 5.2.4 Contract Research Organizations

6 Region

  • 6.1 Regional Summary
  • 6.2 North America
    • 6.2.1 Regional Overview
    • 6.2.2 Driving Factors for Market Growth
    • 6.2.3 Factors Challenging the Market
    • 6.2.4 By Offering
      • 6.2.4.1 By Proteomics Technologies
    • 6.2.5 By Application
    • 6.2.6 By Country
      • 6.2.6.1 U.S.
        • 6.2.6.1.1 By Offering
        • 6.2.6.1.2 Application
      • 6.2.6.2 Canada
        • 6.2.6.2.1 By Offering
        • 6.2.6.2.2 By Application
  • 6.3 Europe
    • 6.3.1 Regional Overview
    • 6.3.2 Driving Factors for Market Growth
    • 6.3.3 Factors Challenging the Market
    • 6.3.4 By Offering
      • 6.3.4.1 By Proteomics Technologies
    • 6.3.5 By Application
    • 6.3.6 By Country
      • 6.3.6.1 U.K.
        • 6.3.6.1.1 By Offering
        • 6.3.6.1.2 By Application
      • 6.3.6.2 Germany
        • 6.3.6.2.1 By Offering
        • 6.3.6.2.2 By Application
      • 6.3.6.3 France
        • 6.3.6.3.1 By Offering
        • 6.3.6.3.2 By Application
      • 6.3.6.4 Italy
        • 6.3.6.4.1 By Offering
        • 6.3.6.4.2 By Application
      • 6.3.6.5 Spain
        • 6.3.6.5.1 By Offering
        • 6.3.6.5.2 By Application
      • 6.3.6.6 Rest-of-Europe
        • 6.3.6.6.1 By Offering
        • 6.3.6.6.2 By Application
  • 6.4 Asia-Pacific
    • 6.4.1 Regional Overview
    • 6.4.2 Driving Factors for Market Growth
    • 6.4.3 Factors Challenging the Market
    • 6.4.4 By Offering
      • 6.4.4.1 By Proteomics Technologies
    • 6.4.5 By Application
    • 6.4.6 By Country
      • 6.4.6.1 Japan
        • 6.4.6.1.1 By Offering
        • 6.4.6.1.2 By Application
      • 6.4.6.2 China
        • 6.4.6.2.1 By Offering
        • 6.4.6.2.2 Application
      • 6.4.6.3 India
        • 6.4.6.3.1 By Offering
        • 6.4.6.3.2 By Application
      • 6.4.6.4 Australia
        • 6.4.6.4.1 By Offering
        • 6.4.6.4.2 By Application
      • 6.4.6.5 South Korea
        • 6.4.6.5.1 By Offering
        • 6.4.6.5.2 By Application
      • 6.4.6.6 Rest-of-Asia-Pacific
        • 6.4.6.6.1 By Offering
        • 6.4.6.6.2 By Application
  • 6.5 Latin America
    • 6.5.1 Regional Overview
    • 6.5.2 Driving Factors for Market Growth
    • 6.5.3 Factors Challenging the Market
    • 6.5.4 By Offering
      • 6.5.4.1 By Proteomics Technologies
    • 6.5.5 By Application
    • 6.5.6 By Country
      • 6.5.6.1 Brazil
        • 6.5.6.1.1 By Offering
        • 6.5.6.1.2 By Application
      • 6.5.6.2 Mexico
        • 6.5.6.2.1 By Offering
        • 6.5.6.2.2 By Application
      • 6.5.6.3 Rest-of-Latin America
        • 6.5.6.3.1 By Offering
        • 6.5.6.3.2 By Application
  • 6.6 Middle East and Africa
    • 6.6.1 Regional Overview
    • 6.6.2 Driving Factors for Market Growth
    • 6.6.3 Factors Challenging the Market
    • 6.6.4 By Offering
      • 6.6.4.1 By Proteomics Technologies
    • 6.6.5 By Application

7 Markets - Competitive Benchmarking & Company Profiles

  • 7.1 Company Profiles
    • 7.1.1 Agilent Technologies, Inc.
      • 7.1.1.1 Overview
      • 7.1.1.2 Top Products/Product Portfolio
      • 7.1.1.3 Top Competitors
      • 7.1.1.4 Target Customers
      • 7.1.1.5 Key Personal
      • 7.1.1.6 Analyst View
    • 7.1.2 Becton, Dickinson and Company
      • 7.1.2.1 Overview
      • 7.1.2.2 Top Products/Product Portfolio
      • 7.1.2.3 Top Competitors
      • 7.1.2.4 Target Customers
      • 7.1.2.5 Key Personal
      • 7.1.2.6 Analyst View
    • 7.1.3 Bio-Rad Laboratories, Inc.
      • 7.1.3.1 Overview
      • 7.1.3.2 Top Products/Product Portfolio
      • 7.1.3.3 Top Competitors
      • 7.1.3.4 Target Customers
      • 7.1.3.5 Key Personal
      • 7.1.3.6 Analyst View
    • 7.1.4 Bruker Corporation
      • 7.1.4.1 Overview
      • 7.1.4.2 Top Products/Product Portfolio
      • 7.1.4.3 Top Competitors
      • 7.1.4.4 Target Customers
      • 7.1.4.5 Key Personal
      • 7.1.4.6 Analyst View
    • 7.1.5 Carterra, Inc.
      • 7.1.5.1 Overview
      • 7.1.5.2 Top Products/Product Portfolio
      • 7.1.5.3 Top Competitors
      • 7.1.5.4 Target Customers
      • 7.1.5.5 Key Personal
      • 7.1.5.6 Analyst View
    • 7.1.6 Danaher Corporation
      • 7.1.6.1 Overview
      • 7.1.6.2 Top Products/Product Portfolio
      • 7.1.6.3 Top Competitors
      • 7.1.6.4 Target Customers
      • 7.1.6.5 Key Personal
      • 7.1.6.6 Analyst View
    • 7.1.7 DiaSorin S.P.A.
      • 7.1.7.1 Overview
      • 7.1.7.2 Top Products/Product Portfolio
      • 7.1.7.3 Top Competitors
      • 7.1.7.4 Target Customers
      • 7.1.7.5 Key Personal
      • 7.1.7.6 Analyst View
    • 7.1.8 Erisyon Inc.
      • 7.1.8.1 Overview
      • 7.1.8.2 Top Products/Product Portfolio
      • 7.1.8.3 Top Competitors
      • 7.1.8.4 Target Customers
      • 7.1.8.5 Key Personal
      • 7.1.8.6 Analyst View
      • 7.1.8.7 Market Share, 2023
    • 7.1.9 Illumina, Inc.
      • 7.1.9.1 Overview
      • 7.1.9.2 Top Products/Product Portfolio
      • 7.1.9.3 Top Competitors
      • 7.1.9.4 Target Customers
      • 7.1.9.5 Key Personal
      • 7.1.9.6 Analyst View
    • 7.1.10 RareCyte Inc.
      • 7.1.10.1 Overview
      • 7.1.10.2 Top Products/Product Portfolio
      • 7.1.10.3 Top Competitors
      • 7.1.10.4 Target Customers
      • 7.1.10.5 Key Personal
      • 7.1.10.6 Analyst View
    • 7.1.11 Quanterix Corporation
      • 7.1.11.1 Overview
      • 7.1.11.2 Top Competitors
      • 7.1.11.3 Target Customers
      • 7.1.11.4 Key Personal
      • 7.1.11.5 Analyst View
      • 7.1.11.6 Market Share, 2023
    • 7.1.12 Quantum-Si Incorporated
      • 7.1.12.1 Overview
      • 7.1.12.2 Top Products/Product Portfolio
      • 7.1.12.3 Top Competitors
      • 7.1.12.4 Target Customers
      • 7.1.12.5 Key Personal
      • 7.1.12.6 Analyst View
    • 7.1.13 Shimadzu Corporation
      • 7.1.13.1 Overview
      • 7.1.13.2 Top Products/Product Portfolio
      • 7.1.13.3 Top Competitors
      • 7.1.13.4 Target Customers
      • 7.1.13.5 Key Personal
      • 7.1.13.6 Analyst View
    • 7.1.14 Standard BioTools Inc.
      • 7.1.14.1 Overview
      • 7.1.14.2 Top Products/Product Portfolio
      • 7.1.14.3 Top Competitors
      • 7.1.14.4 Target Customers
      • 7.1.14.5 Key Personal
      • 7.1.14.6 Analyst View
    • 7.1.15 Thermo Fisher Scientific Inc.
      • 7.1.15.1 Overview
      • 7.1.15.2 Top Products/Product Portfolio
      • 7.1.15.3 Top Competitors
      • 7.1.15.4 Target Customers
      • 7.1.15.5 Key Personal
      • 7.1.15.6 Analyst View
    • 7.1.16 Waters Corporation
      • 7.1.16.1 Overview
      • 7.1.16.2 Top Products/Product Portfolio
      • 7.1.16.3 Top Competitors
      • 7.1.16.4 Target Customers
      • 7.1.16.5 Key Personal
      • 7.1.16.6 Analyst View

8 Research Methodology

  • 8.1 Data Sources
    • 8.1.1 Primary Data Sources
    • 8.1.2 Secondary Data Sources
    • 8.1.3 Data Triangulation
  • 8.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Proteomics Market (by Scenario), $Billion, 2024, 2030, and 2035
  • Figure 2: Global Proteomics Market, $Billion, 2024 and 2035
  • Figure 3: Global Proteomics Market (by Offering), $Billion, 2024, 2030, and 2035
  • Figure 4: Global Proteomics Market (by Application), $Billion, 2024, 2030, and 2035
  • Figure 5: Global Proteomics Market (by Technology), $Billion, 2024, 2030, and 2035
  • Figure 6: Global Proteomics Market (by End User), $Billion, 2024, 2030, and 2035
  • Figure 7: Global Proteomics Market Segmentation
  • Figure 8: Ecosystem Global Proteomics Market
  • Figure 9: Supply Chain and Risks within the Supply Chain
  • Figure 10: Global Proteomics Market, Patent Analysis (by Year), January 2021-December 2024
  • Figure 11: Global Proteomics Market, Patent Analysis (by Country), January 2021-December 2024
  • Figure 12: Global Proteomics Market (by Offering), $Billion, 2024, 2030, and 2035
  • Figure 13: Global Proteomics Market (Sample Preparation), $Billion, 2024-2035
  • Figure 14: Global Proteomics Market (Proteomics Technologies), $Billion, 2024-2035
  • Figure 15: Global Proteomics Market (by Proteomics Technologies, Reagents and Consumables), $Billion, 2024-2035
  • Figure 16: Global Proteomics Market (by Reagents and Consumables, MS-Based Reagents), $Billion, 2024-2035
  • Figure 17: Global Proteomics Market (by Reagents and Consumables, Chromatography-Based Reagents), $Billion, 2024-2035
  • Figure 18: Global Proteomics Market (by Reagents and Consumables, Protein Microarray Reagents), $Billion, 2024-2035
  • Figure 19: Global Proteomics Market (by Reagents and Consumables, Single-Cell Analysis Reagents), $Billion, 2024-2035
  • Figure 20: Global Proteomics Market (by Reagents and Consumables, NGS-Based Reagents), $Billion, 2024-2035
  • Figure 21: Global Proteomics Market (by Reagents and Consumables, Other Reagents), $Billion, 2024-2035
  • Figure 22: Global Proteomics Market (by Proteomics Technologies, Instruments), $Billion, 2024-2035
  • Figure 23: Global Proteomics Market (by Instruments, Mass Spectrometers), $Billion, 2024-2035
  • Figure 24: Global Proteomics Market (by Instruments, Chromatography Systems), $Billion, 2024-2035
  • Figure 25: Global Proteomics Market (by Instruments, Protein Microarrays), $Billion, 2024-2035
  • Figure 26: Global Proteomics Market (by Instruments, Single-Cell Analysis Instruments), $Billion, 2024-2035
  • Figure 27: Global Proteomics Market (by Instruments, NGS Instruments), $Billion, 2024-2035
  • Figure 28: Global Proteomics Market (by Instruments, Other Instruments), $Billion, 2024-2035
  • Figure 29: Global Proteomics Market (by Proteomics Technologies, Software), $Billion, 2024-2035
  • Figure 30: Global Proteomics Market (by Software, AI-Based Proteomics Analysis Tools), $Billion, 2024-2035
  • Figure 31: Global Proteomics Market (by Software, Spatial Proteomics Data Analytic Software), $Billion, 2024-2035
  • Figure 32: Global Proteomics Market (by Software, Cloud-Based Platforms), $Billion, 2024-2035
  • Figure 33: Global Proteomics Market (Proteomics Services), $Billion, 2024-2035
  • Figure 34: Global Proteomics Market (by Application), $Billion, 2024, 2030, and 2035
  • Figure 35: Global Proteomics Market (Biomarker Discovery and Validation), $Billion, 2024-2035
  • Figure 36: Global Proteomics Market (Proteomics Profiling and Mapping), $Billion, 2024-2035
  • Figure 37: Global Proteomics Market (Drug Discovery and Development), $Billion, 2024-2035
  • Figure 38: Global Proteomics Market (by Drug Discovery and Development, Discovery), $Billion, 2024-2035
  • Figure 39: Global Proteomics Market (by Discovery, Target Identification and Validation), $Billion, 2024-2035
  • Figure 40: Global Proteomics Market (by Discovery, Others), $Billion, 2024-2035
  • Figure 41: Global Proteomics Market (by Drug Discovery and Development, Preclinical), $Billion, 2024-2035
  • Figure 42: Global Proteomics Market (by Drug Discovery and Development, Clinical), $Billion, 2024-2035
  • Figure 43: Global Proteomics Market (Companion Diagnostics), $Billion, 2024-2035
  • Figure 44: Global Proteomics Market (Protein-Protein Interactions), $Billion, 2024-2035
  • Figure 45: Global Proteomics Market (by Technology), $Billion, 2024, 2030, and 2035
  • Figure 46: Global Proteomics Market (Mass Spectrometry-Based Proteomics), $Billion, 2024-2035
  • Figure 47: Global Proteomics Market (Chromatography-Based Proteomics), $Billion, 2024-2035
  • Figure 48: Global Proteomics Market (Protein Microarray), $Billion, 2024-2035
  • Figure 49: Global Proteomics Market (Single-Cell Proteomics), $Billion, 2024-2035
  • Figure 50: Global Proteomics Market (NGS-Based Proteomics), $Billion, 2024-2035
  • Figure 51: Global Proteomics Market (Other Technologies), $Billion, 2024-2035
  • Figure 52: Global Proteomics Market (by Application), $Billion, 2024, 2030, and 2035
  • Figure 53: Global Proteomics Market (Academic and Research Institutions), $Billion, 2024-2035
  • Figure 54: Global Proteomics Market (Pharmaceutical and Biotechnology Companies), $Billion, 2024-2035
  • Figure 55: Global Proteomics Market (Hospitals and Clinical Diagnostics Laboratories), $Billion, 2024-2035
  • Figure 56: Global Proteomics Market (Contract Research Organizations), $Billion, 2024-2035
  • Figure 57: U.S. Proteomics Market, $Billion, 2024-2035
  • Figure 58: Canada Proteomics Market, $Billion, 2024-2035
  • Figure 59: U.K. Proteomics Market, $Billion, 2024-2035
  • Figure 60: Germany Proteomics Market, $Billion, 2024-2035
  • Figure 61: France Proteomics Market, $Billion, 2024-2035
  • Figure 62: Italy Proteomics Market, $Billion, 2024-2035
  • Figure 63: Spain Proteomics Market, $Billion, 2024-2035
  • Figure 64: Rest-of-Europe Proteomics Market, $Billion, 2024-2035
  • Figure 65: Japan Proteomics Market, $Billion, 2024-2035
  • Figure 66: China Proteomics Market, $Billion, 2024-2035
  • Figure 67: India Proteomics Market, $Billion, 2024-2035
  • Figure 68: Australia Proteomics Market, $Billion, 2024-2035
  • Figure 69: South Korea Proteomics Market, $Billion, 2024-2035
  • Figure 70: Rest-of-Asia-Pacific Proteomics Market, $Billion, 2024-2035
  • Figure 71: Brazil Proteomics Market, $Billion, 2024-2035
  • Figure 72: Mexico Proteomics Market, $Billion, 2024-2035
  • Figure 73: Rest-of-Latin America Proteomics Market, $Billion, 2024-2035
  • Figure 74: Data Triangulation
  • Figure 75: Top-Down and Bottom-Up Approach
  • Figure 76: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Opportunities across Regions
  • Table 3: Partnerships and Collaborations in the Global Proteomics Market
  • Table 4: Global Proteomics Market, Product Benchmarking (by Technology)
  • Table 5: Global Proteomics Market (by Region), $Billion, 2024-2035
  • Table 6: North America Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 7: North America Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 8: North America Proteomics Market (by Application), $Billion, 2024-2035
  • Table 9: U.S. Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 10: U.S. Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 11: U.S. Proteomics Market (by Application), $Billion, 2024-2035
  • Table 12: Canada Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 13: Canada Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 14: Canada Proteomics Market (by Application), $Billion, 2024-2035
  • Table 15: Europe Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 16: Europe Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 17: Europe Proteomics Market (by Application), $Billion, 2024-2035
  • Table 18: U.K. Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 19: U.K. Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 20: U.K. Proteomics Market (by Application), $Billion, 2024-2035
  • Table 21: Germany Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 22: Germany Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 23: Germany Proteomics Market (by Application), $Billion, 2024-2035
  • Table 24: France Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 25: France Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 26: France Proteomics Market (by Application), $Billion, 2024-2035
  • Table 27: Italy Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 28: Italy Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 29: Italy Proteomics Market (by Application), $Billion, 2024-2035
  • Table 30: Spain Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 31: Spain Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 32: Spain Proteomics Market (by Application), $Billion, 2024-2035
  • Table 33: Rest-of-Europe Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 34: Rest-of-Europe Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 35: Rest-of-Europe Proteomics Market (by Application), $Billion, 2024-2035
  • Table 36: Asia-Pacific Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 37: Asia-Pacific Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 38: Asia-Pacific Proteomics Market (by Application), $Billion, 2024-2035
  • Table 39: Japan Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 40: Japan Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 41: Japan Proteomics Market (by Application), $Billion, 2024-2035
  • Table 42: China Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 43: China Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 44: China Proteomics Market (by Application), $Billion, 2024-2035
  • Table 45: India Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 46: India Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 47: India Proteomics Market (by Application), $Billion, 2024-2035
  • Table 48: Australia Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 49: Australia Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 50: Australia Proteomics Market (by Application), $Billion, 2024-2035
  • Table 51: South Korea Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 52: South Korea Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 53: South Korea Proteomics Market (by Application), $Billion, 2024-2035
  • Table 54: Rest-of-Asia-Pacific Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 55: Rest-of-Asia-Pacific Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 56: Rest-of-Asia-Pacific Proteomics Market (by Application), $Billion, 2024-2035
  • Table 57: Latin America Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 58: Latin America Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 59: Latin America Proteomics Market (by Application), $Billion, 2024-2035
  • Table 60: Brazil Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 61: Brazil Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 62: Brazil Proteomics Market (by Application), $Billion, 2024-2035
  • Table 63: Mexico Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 64: Mexico Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 65: Mexico Proteomics Market (by Application), $Billion, 2024-2035
  • Table 66: Rest-of-Latin America Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 67: Rest-of-Latin America Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 68: Rest-of-Latin America Proteomics Market (by Application), $Billion, 2024-2035
  • Table 69: Middle East and Africa Proteomics Market (by Offering), $Billion, 2024-2035
  • Table 70: Middle East and Africa Proteomics Market (by Proteomics Technologies), $Billion, 2024-2035
  • Table 71: Middle East and Africa Proteomics Market (by Application), $Billion, 2024-2035